,

9

1

8

t

,

9

4

2

t

,

2

1

3

1

t

fo

r

a

p

n

e

a

,

2

1

8

9

fo

r

a

s

thma

,

3

9

3

fo

r

c

hr

o

nic

a

s

thma

,

3

9

7

–

3

9

9

fo

r

C

O

P

D

,

4

2

4

do

s

e

s

o

f,

3

9

7

–

3

9

8

,

3

9

8

t

drug

int

e

r

a

c

t

io

n

s

,

3

9

8

–

3

9

9

drug

int

e

r

a

c

t

io

n

w

ith

s

mo

kin

g

,

1

9

0

6

t

a

n

d

dy

s

p

e

p

s

ia

,

4

8

7

fa

c

t

o

r

s

a

ffe

c

t

in

g

,

3

9

9

t

GE

R

D

a

n

d

,

5

0

3

t

a

n

d

lith

ium

,

1

8

4

3

t

t

o

x

ic

ity

o

f,

3

9

8

T

h

i

a

m

i

n

e

,

a

l

c

o

h

o

l

wi

t

h

d

r

awa

l

,

1

8

9

6

T

h

i

azi

d

e

d

i

u

r

e

t

i

c

s

,

5

8

0

,

6

0

9

,

8

9

1

,

9

1

7

t

fo

r

B

P

D

,

2

1

7

4

fo

r

hyp

e

r

t

e

n

s

io

n

,

1

4

0

a

n

d

hyp

o

ka

le

mia

,

5

8

3

t

fo

r

v

a

s

c

ula

r

d

e

me

nt

ia

,

2

2

4

2

T

h

i

azi

d

e

-

l

i

k

e

d

i

u

r

e

t

i

c

s

,

a

n

d

A

I

N

,

6

4

5

T

h

i

azi

d

e

s

,

2

7

0

fo

r

hyp

e

r

t

e

n

s

io

n

,

1

4

7

–

1

4

8

,

1

4

8

–

1

4

9

t

T

h

i

az

o

l

i

d

i

n

e

d

i

o

n

e

s

a

dv

e

r

s

e

e

ffe

c

t

s

o

f,

1

1

2

4

c

o

ntr

a

in

dic

a

t

io

n

s

a

n

d

p

r

e

c

a

ut

io

n

s

o

f,

1

1

2

4

do

s

a

g

e

a

n

d

c

linic

a

l

u

s

e

,

1

1

2

5

drug

int

e

r

a

c

t

io

n

s

,

1

1

2

4–

1

1

2

5

e

ffic

a

c

y

o

f,

1

1

2

5

me

c

h

a

nis

m

o

f

a

c

t

io

n

,

1

1

2

3

p

h

a

r

ma

c

o

kin

e

t

ic

s

o

f,

1

1

2

4

T

h

i

o

a

m

i

d

e

s

,

1

0

4

2

,

1

0

5

7

,

1

0

6

5

a

dminis

tr

a

t

io

n

o

f,

1

0

6

0–

1

0

6

1

a

dv

e

r

s

e

e

ffe

c

t

s

,

1

0

6

2

a

n

d

a

gr

a

nulo

c

yt

o

s

is

,

1

0

6

2

–

1

0

6

3

dis

a

dv

a

nt

a

g

e

s

o

f,

1

0

5

8

do

s

a

g

e

,

1

0

6

0–

1

0

6

1

dur

a

t

io

n

o

f,

1

0

6

1

p. 2

3

1

5

p. 2

3

1

6

a

n

d

gr

a

nulo

c

yt

op

e

nia

,

1

0

6

2

–

1

0

6

3

a

n

d

h

e

p

a

t

it

is

,

1

0

6

2

mo

nit

o

r

in

g

o

f,

1

0

6

1

p

r

e

c

a

ut

io

n

s

,

1

0

6

1

r

a

s

h

e

s

fr

o

m

,

1

0

6

2

r

e

mis

s

io

n

r

a

t

e

s

w

ith

,

1

0

6

3

T

h

i

o

g

u

a

n

i

n

e

(

T

a

b

l

o

i

d

)

,

4

7

0

t

,

1

9

7

8

t

fo

r

T

-

c

e

ll

lymp

h

o

ma

s

,

2

0

2

0

t

T

h

i

o

m

e

r

s

a

l

,

8

2

2

t

T

h

i

o

p

e

n

t

a

l

,

1

6

7

2

,

2

1

9

8

T

h

i

o

p

u

ri

n

e

,

5

6

,

5

6

t

,

9

1

7

t